No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Traws Pharma | 10-K: FY2024 Annual Report
Express News | Traws Pharma Inc - Cash Runway to Support Operations Into Q1 2026
Traws Pharma: Cash, Cash Equivalents, Short-Term Investments of About $21.3M As of Dec 31 >TRAW
Traws Pharma 2024 Loss/Shr $35.21 >TRAW
Traws Pharma Reports Full Year 2024 Results and Business Highlights
Traws Pharma Werner Cautreels To Retire As CEO; Iain D. Dukes, D Phil, Executive Board Chairman, To Become Interim CEO, Effective On Or About Close Of Business On March 31, 2025